I think Padbury should backdoor list a pharmaceutical company. Or maybe a hair transplant company, which really would be ironic. A year ago on 11th April they had secured full non-dilutory funding of US$6.7 billion from a SMSF.
PDY Price at posting:
0.7¢ Sentiment: None Disclosure: Not Held